Results 261 to 270 of about 138,331 (318)
Impact of metabolic and bariatric surgery on the paediatric & adolescent metabolome: A systematic review and meta-analysis. [PDF]
Mitra AT +6 more
europepmc +1 more source
Oxyntomodulin physiology and its therapeutic development in obesity and associated complications
Abstract figure legend Physiological influences of OXM and its emerging insights from evidence on bariatric surgery effects. CCK, cholecystokinin; FGF21, fibroblast growth factor 21; GLUT4, glucose transporter type 4; IRS1, insulin receptor substrate‐1; NNMT, nicotinamide N‐methyltransferase; OXM, oxyntomodulin Abstract Incretins, such as glucagon‐like
Martin T. W. Kueh +3 more
wiley +1 more source
Evaluating the Efficacy of Neurofeedback in Post-Bariatric Surgery Patients: A Pilot Study. [PDF]
Scaramuzzino C +8 more
europepmc +1 more source
Predictors of Delayed Recovery in Ambulatory Advanced Endoscopic Procedures
ABSTRACT Background There is a scarcity of data evaluating patient‐related outcomes of advanced or complex endoscopy (ACE) through the post‐anesthesia recovery course. Yet, gastrointestinal distress following ACE can occur commonly, and this may impact recovery length of stay and the approach to post‐anesthesia care.
Zoilo K. Suarez +8 more
wiley +1 more source
Bariatric Surgery and Incident Development of Obesity-Related Comorbidities.
Bader AL +6 more
europepmc +1 more source
Quinoa intervention counteracts high‐fat diet (HFD)‐induced obesity in C57BL/6 female mice and elicits a concomitant increase in the relative abundance of Bacteroidota, Bacteroidia, Bacteroidales, and Muribaculaceae. Treatment with quinoa in HFD‐fed female mice results in reduced expression of genes involved in “ion channel” in gonadal white adipose ...
Yingqi Liu +13 more
wiley +1 more source
Risk Factors for Cardiovascular and Metabolic Disease: Integrating Traditional and Novel Paradigms
ABSTRACT Cardiovascular and metabolic diseases (CVMD), encompassing atherosclerotic cardiovascular disease (ASCVD), heart failure, obesity, type 2 diabetes mellitus (T2DM), and metabolic dysfunction‐associated steatotic liver disease (MASLD), remain the leading global cause of morbidity and mortality.
Zhihua Wang +3 more
wiley +1 more source
Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists.
Barrett TS +4 more
europepmc +1 more source
The Economics of Liver Fibrosis Diagnosis: Systematic Review of Non‐Invasive Test Cost‐Effectiveness
ABSTRACT Hepatic diseases progress silently, leading to fibrosis, cirrhosis, and hepatocellular carcinoma. Although liver biopsy remains the gold standard for fibrosis assessment, it is limited by invasiveness and sampling variability. Non‐invasive liver tests (NILTs) can mitigate biopsy‐related risks.
Marilia Mastrocolla de Almeida Cardoso +7 more
wiley +1 more source

